Home›Companies›Healthcare›Cardiosense

Cardiosense, Inc.

Wearable heart pressure monitoring equipment for clinicians treating patients with heart failure.

Updated Nov 9, 2026·Latest SEC filing Aug 24, 2026·Suggest an edit

About Cardiosense

Cardiosense is a private company based in Chicago, Illinois. It has reported $35,221,377 raised in two offerings on Form D since December 2022. Its chief executive is Eric Meizlish.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Aug 7, 2026Aug 24, 2026$26,137,050of $42.0M target30$871KEquity, Securities on exercise, Convertible Promissory Notes have converted into equity in connection with this transactionRule 506(b)Form D ↗
Nov 29, 2022Dec 9, 2022$9,084,327of $17.6M target28$324KEquityRule 506(b)Form D ↗
Total, two offerings$35,221,377

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Cardiosense's Form D filed Aug 24, 2026.

DG
Daniel Gottlieb
Director
Also a director at XII Medical.
BS
Bimal Shah
Director
Eric Meizlish
Eric Meizlish
Chief Executive Officer and director
Andrew Carek
Andrew Carek
Co-founder, Chief Technical Officer
JT
Jeffrey Trost
Director
Also a director at Avive Solutions and Tele911.
Omer Inan
Omer Inan
Co-founder, Chief Scientific Officer and director

Earlier filings also listed Jeff Terrell (director, last listed Dec 2022) and Amit Gupta (chief executive officer and director, last listed Dec 2022).

Sources

  1. SECCardiosense, Inc. filing history
  2. PressCardiosense Series A announcement